This study investigates the potential of monocyte-derived dendritic cells (IFN-DCs), generated in the presence of interferon-α (IFN-α) and granulocyte-macrophage colony-stimulating factor (GM-CSF) [11,12], and loaded with oxidized tumor cell lysate from patient-specific organoids to activate immune responses against BC cells. This evidence concerns the gene IFNA2 and neoplasm.